UPLIZNA (inebilizumab) is a monoclonal antibody targeting the CD19 cell surface marker on B-cells and is building strong momentum as a multi-indication autoimmune franchise. UPLIZNA is FDA-approved for the treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD), IgG4-Related Disease (IgG4-RD), and most recently, Generalized Myasthenia Gravis (gMG)—a chronic autoimmune disease driven by pathogenic autoantibodies that impair neuromuscular transmission and lead to muscle weakness. With multiple approved indications and continued expansion, UPLIZNA is entering a pivotal phase of growth. The gMG launch represents a significant opportunity to establish UPLIZNA as a foundational therapy within neurology and help more patients around the world. The UPLIZNA gMG HCP Marketing Sr. Manager will play a central role in shaping and executing a high-impact launch. This leader will drive the gMG HCP strategy, elevate disease and brand education among neurologists, and clearly differentiate UPLIZNA’s value in a competitive landscape. The role requires strong cross-functional leadership across medical, sales, market access, and commercial teams to build on a best-in-class launch. Success in this role requires a launch mindset, strategic agility, and a strong focus on execution—paired with a passion for improving patient outcomes and a commitment to excellence.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Manager
Education Level
High school or GED
Number of Employees
5,001-10,000 employees